Julien Seneschal
Overview
Explore the profile of Julien Seneschal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
1792
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Strizzolo R, Seneschal J, Soria A, Staumont-Salle D, Barbarot S, Viguier M, et al.
World Allergy Organ J
. 2024 Aug;
17(7):100923.
PMID: 39157196
In patients with moderate to severe atopic dermatitis (AD) showing an inadequate response to dupilumab 300mg/2weeks, few real-life studies reported the response to alternative regimen maintaining dupilumab. To assess and...
12.
Kpenou F, Paul C, Seneschal J, Andreu N, Barbarot S, Tauber M, et al.
Br J Dermatol
. 2024 Aug;
192(1):162-163.
PMID: 39154353
No abstract available.
13.
Repigmentation by body region in patients with vitiligo treated with ruxolitinib cream over 52 weeks
Passeron T, Harris J, Pandya A, Seneschal J, Grimes P, Kornacki D, et al.
J Eur Acad Dermatol Venereol
. 2024 Jul;
39(3):e251-e254.
PMID: 39011655
No abstract available.
14.
Migayron L, Bordes S, Closs B, Seneschal J, Boniface K
Front Immunol
. 2024 Jun;
15:1405215.
PMID: 38868763
Chronic inflammatory skin diseases are multifactorial diseases that combine genetic predisposition, environmental triggers, and metabolic disturbances associated with abnormal immune responses. From an immunological perspective, the better understanding of their...
15.
Seneschal J
J Eur Acad Dermatol Venereol
. 2024 Mar;
38(4):631-632.
PMID: 38523486
No abstract available.
16.
Knobler R, Geroldinger-Simic M, Kreuter A, Hunzelmann N, Moinzadeh P, Rongioletti F, et al.
J Eur Acad Dermatol Venereol
. 2024 Mar;
38(7):1281-1299.
PMID: 38456518
The term 'sclerosing diseases of the skin' comprises specific dermatological entities, which have fibrotic changes of the skin in common. These diseases mostly manifest in different clinical subtypes according to...
17.
Seneschal J, Boniface K
Dermatol Pract Concept
. 2024 Jan;
13(4S2).
PMID: 38241396
The current management of vitiligo remains challenging; however, different strategies can be proposed to patients with a good efficacy in many cases. First, it is important to identify patients in...
18.
Seneschal J
Dermatol Pract Concept
. 2024 Jan;
13(4S2).
PMID: 38241394
Vitiligo is the most common cause of depigmentation and its estimated worldwide prevalence ranges from 0.5% to 2%. The disease is characterized by the development of white macules resulting from...
19.
Fakih A, Tannous R, Lajnef M, Seneschal J, Andreu N, Tran V, et al.
Br J Dermatol
. 2024 Jan;
190(5):712-717.
PMID: 38234050
Background: Vitiligo is the most common cause of skin depigmentation worldwide. Patients with vitiligo may experience stigma and this needs to be addressed. Objectives: To evaluate stigma in patients with...
20.
Guttman-Yassky E, Facheris P, Gomez-Arias P, Del Duca E, Da Rosa J, Weidinger S, et al.
Allergy
. 2023 Dec;
79(5):1258-1270.
PMID: 38108208
Background: This is the first report on the effects of abrocitinib, a Janus kinase 1-selective inhibitor, on the expression of skin biomarkers in patients with moderate-to-severe atopic dermatitis (AD). Methods:...